img

As per recent reports, Namita Thapar's current investment in Emcure Pharmaceuticals Limited grew by a massive 38,200% to ₹671 crore - following the company's 31% listing premium on the NSE. Let's take a closer look at her iconic entrepreneurial and investment journey

Emcure Pharmaceuticals' ₹1,952 Cr IPO received 67.87 times subscription on the final day of the offer on Friday.

In 2007, after her MBA and a successful stint at a US medical device company - Namita returned to India to join her family business, Emcure, as the CFO and was soon appointed as the Executive Director.

In 2021, the company reported a profit of Rs 418 crore on a revenue of Rs 6091 crore!

In addition to Emcure, Thapar leads Incredible Ventures Ltd, an education company that teaches entrepreneurship to 11 to 18-year-olds.

"Namita Thapar Entrepreneur Indian Entrepreneur Women in business Startup Success pharmaceutical industry business leader inspirational women entrepreneurial journey Startup Stories Indian startup ecosystem Women Empowerment Business Inspiration Leadership startup founder pharmaceutical leader".